4//SEC Filing
Vardzel Gerald J Jr 4
Accession 0001179110-19-004822
CIK 0001446159other
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 4:38 PM ET
Size
9.0 KB
Accession
0001179110-19-004822
Insider Transaction Report
Form 4
Vardzel Gerald J Jr
Director
Transactions
- Award
Common Stock, $.01 par value
2019-04-04+718,205→ 718,205 total - Award
Stock Options (right to buy)
2019-04-04+151,260→ 151,260 totalExercise: $0.75Exp: 2029-04-04→ Common Stock (151,260 underlying) - Other
Common Stock, $.01 par value
2019-04-04+197,506→ 197,506 total
Footnotes (3)
- [F1]The reporting person acquired 718,205 shares of issuer common stock in exchange for an 18% interest in Helomics Holding Corporation ("Helomics") pursuant to Helomics merger into the issuer. The shares are valued at $0.7480 per share, the closing price on the date of the closing, 4/4/2019. Of the 718,205 shares issued to the reporting person in the merger, 175,411 are currently being held in escrow and are subject to forfeiture during the escrow period (until 9/30/2020), to satisfy any claims arising as a result of any breach by Helomics of any of its representations and warranties or covenants in the merger agreement.
- [F2]Shares released from escrow.
- [F3]37,815 shares vest immediately and 37,815 vest on 10/4/2019; the remainder vests quarterly for 18 months.
Documents
Issuer
Precision Therapeutics Inc.
CIK 0001446159
Entity typeother
Related Parties
1- filerCIK 0001751315
Filing Metadata
- Form type
- 4
- Filed
- Apr 7, 8:00 PM ET
- Accepted
- Apr 8, 4:38 PM ET
- Size
- 9.0 KB